CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 25 enrolled
Drug / intervention
Virtual Reality Programother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06318338
NCT06318338N/ACompleted
CompareCT.gov

Virtual Reality to Promote Mindfulness and Relaxation Prior to Radiation Simulation: A Prospective Pilot Feasibility Study

Abramson Cancer Center at Penn Medicine·interventional·Posted Mar 19, 2024·Updated Mar 27, 2026

In Brief

A clinical study evaluating Virtual Reality Program for Cancer. Completed, enrolled 25 participants across 1 site.

Detailed Summary

The purpose of this study is to assess the feasibility of a pre-simulation virtual reality (VR) platform designed to promote relaxation for cancer patients planned for radiation therapy (RT).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCancer
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20252026
First PostedMar 19, 2024
Enrollment StartApr 8, 2024
Primary CompletionFeb 12, 2025
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 2.3 years ago

Interventions

Virtual Reality Programother

Study participants will be provided a HTC or Pico VR head-mounted device (HTC Flow, HTC Focus or Pico Neo Pro) which will be fitted for comfort. Patients will remain seated for the entirety of the VR program. The program generally takes about ten minutes to complete but may last up to 11 minutes. The program displays a relaxing environmental setting with narration based in mindfulness meditation principles. Subjects will be prompted to practice breathing exercises designed to relax and reduce anxiety.